0	12	Constitutive	constitutive	JJ
13	23	expression	expression	NN
24	26	of	of	IN
27	32	HIV-1	HIV-1	NNP
33	36	tat	tat	NN
37	44	protein	protein	NN
45	47	in	in	IN
48	53	human	human	JJ
54	60	Jurkat	Jurkat	NNP
61	62	T	t	NN
63	68	cells	cell	NNS
69	74	using	use	VBG
75	76	a	a	DT
77	79	BK	BK	NNP
80	85	virus	virus	NN
86	92	vector	vector	NN
92	93	.	.	.

95	98	The	the	DT
99	109	production	production	NN
110	113	and	and	CC
114	130	characterization	characterization	NN
131	133	of	of	IN
134	140	Jurkat	Jurkat	NNP
141	145	cell	cell	NN
146	151	lines	line	NNS
152	156	that	that	WDT
157	171	constitutively	constitutively	RB
172	179	express	express	VBP
180	190	functional	functional	JJ
191	196	human	human	JJ
197	203	immune	immune	JJ
204	214	deficiency	deficiency	NN
215	220	virus	virus	NN
221	225	type	type	NN
226	227	1	1	CD
228	229	(	(	(
229	234	HIV-1	HIV-1	NNP
234	235	)	)	)
236	239	tat	tat	NN
240	247	protein	protein	NN
247	248	,	,	,
249	254	using	use	VBG
255	256	a	a	DT
257	259	BK	BK	NNP
260	265	virus	virus	NN
266	273	plasmid	plasmid	NN
274	284	expression	expression	NN
285	291	vector	vector	NN
292	295	and	and	CC
296	301	HIV-1	HIV-1	NNP
302	305	tat	tat	NN
306	310	cDNA	cDNA	NNP
310	311	,	,	,
312	314	is	be	VBZ
315	324	described	describe	VBN
324	325	.	.	.

326	328	An	an	DT
329	338	increased	increase	VBN
339	345	growth	growth	NN
346	350	rate	rate	NN
351	353	of	of	IN
354	359	these	these	DT
360	370	Jurkat-tat	Jurkat-tat	NNP
371	375	cell	cell	NN
376	381	lines	line	NNS
382	384	as	as	IN
385	393	compared	compare	VBN
394	398	with	with	IN
399	406	control	control	NN
407	411	cell	cell	NN
412	417	lines	line	NNS
418	421	was	be	VBD
422	430	observed	observe	VBN
430	431	.	.	.